<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210315050709N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-09-14</date_registration>
      <primary_sponsor>Shiraz University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of lumbopelvic manipulation,with lumbopelvic manipulation and dry needling of quadratus lumbarom and Gluteus Medius muscles on pain and function of athletes knee with patellofemoral pain syndrome (PFPS)</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of lumbopelvic manipulation,with lumbopelvic manipulation and dry needling of quadratus lumbarom and Gluteus Medius muscles on pain and function of athletes knee with patellofemoral pain syndrome (PFPS)</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/55935</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: blocked randomization
In this way, we placed 30 cases in blocks and 4-person cases
 Each block is randomly assigned to the control and intervention group, Blinding description: At the beginning of the treatment and at the end of the treatment, she is kept blind. At the beginning, the evaluation is done and at the end, the final evaluation and data recording is done.
Initially, the case is studied in an intervention or control group and the therapist performs treatment for each case depending on whether it is control or intervention, but the evaluator is blind at the beginning of the pre-treatment and post-treatment evaluation and not know about the treatment is performed. And the case of treatment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>patella femoral pain syndrom(pfps).</hc_freetext>
      <i_freetext>Intervention 1: Control group: lumbopelvic manipulation(In this group, only lumbar-pelvic placment is performed, in which the person is placed in a special position and the technique is performed). Intervention 2: Intervention group: lumbopelvic manipulation and dry needling of quadratus lumbarom and Gluteus Medius muscles.(In this group, in addition to pelvic lumbar placement in the said muscles, the dry needle technique is also applied).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Amin Shakouri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 8, jahad Blvd Amin clinic physiotherapy</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7619738513</zip>
        <telephone>+98 34 3282 1128</telephone>
        <email>hd136767@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Amin Shakouri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No 8, jahad Blvd Amin clinic physiotherapy</address>
        <city>Kerman</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7619738513</zip>
        <telephone>+98 34 3282 1128</telephone>
        <email>hd136767@gmail.com</email>
        <affiliation>Shiraz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Athlete 18 to 45 years old with patellofemoral pain syndrome who exercise regularly (at least three times per week)
Complain of anterior knee pain at least in 2 of the following activity: sitting for long periods of time, going up and down stairs, squatting, kneeling, jumping and running
Pain report when touching internal and external of patella surface and positive clarke test in knee extended and sitting
At least be positive result of one of the three following tests:Positive vastus medialis co-ordination test Positive 20 cm going down stair test Positive Patellar apprehension test
Gradual start of symptoms without history of trauma or injury for at least past 3 months
kujala score level 40  to 70
At least 3 out of 10 score level of NPRS in past tree weeks</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Existence of other pathologies of knee joint such as rupture of meniscus or knee ligaments, knee joint wear, tendon problems, patellar dislocation or partial dislocation, Sinding-Larsen disease, Osgood-Schlatter disease and Plica syndrome, ankle and knee injuries.
Pathologies of the hip such as rupture of the ligaments of the thigh, joint wear and tear, tendon problems, dislocation or partial dislocation and injury of the thigh.
Structural and biomechanical problems such as: valgus and varus in the knee or femoral anterior
Radicular pain in the lumbar region and neurological symptoms (diagnosis with the help of history and lower limb percussion test, dural stretch test)
Previous knee surgery
Neurological disorders affecting balance
Contraindications to using dry needles such as: Existence of metabolic diseases including diabetes, rheumatic diseases To. Pregnancy. Respiratory and cardiovascular problems (Peripheral vascular disease), cancer and any malignancy. Immune system defects. Menstruation. Needle phobia. Bleeding disorders and taking anticoagulants. Liver and kidney diseases</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M22.2</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Patellofemoral disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: lumbopelvic manipulation(In this group, only lumbar-pelvic placment is performed, in which the person is placed in a special position and the technique is performed)</i_keyword>
      <i_keyword>Intervention group: lumbopelvic manipulation and dry needling of quadratus lumbarom and Gluteus Medius muscles.(In this group, in addition to pelvic lumbar placement in the said muscles, the dry needle technique is also applied)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain score. Timepoint: At the beginning of the study (before the intervention) and sessions 4 and 1 month later. Method of measurement: Numeric Pain Rating Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Functional ability. Timepoint: At the beginning of the study (before the intervention) and sessions 4 and 1 month later. Method of measurement: Kojala Questionnaire.</sec_outcome>
      <sec_outcome>Functional ability. Timepoint: At the beginning of the study (before the intervention) and sessions 4 and 1 month later. Method of measurement: Lateral plank duration.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-02-24</approval_date>
        <contact_name>Ethics committee of Shiraz University of Medical Sciences</contact_name>
        <contact_address>School of Rehabilitation, Abiverdi 1 St، Chamran Blvd. shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
